Drugs / Vigiis 101-LAB
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03722433 | Aug 2018 → Jul 2019 | Helicobacter pylori infectious disease | National Taiwan University Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vigiis 101-LAB | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03722433 ↗ |
| Modality | Other / unclassified | “Vigiis 101-LAB is the probiotic containing Lactobacillus paracasei subsp. Paracasei” NCT03722433 ↗ |